GleamWall
中文EN

HAE HAEMONETICS CORP

Surgical & Medical Instruments & Apparatus · NYSE · SEC CIK 313143 · Fiscal year ends 04/03

Financial factors as of 2026-09-26 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY4.1%
TTM net income YoY-38.2%
TTM EPS YoY-33.9%
Revenue 3-yr CAGR3.7%
Net income 3-yr CAGR-6.8%

Margins

Gross margin59.6%
Operating margin12.8%
Net margin7.5%
FCF margin21.6%
EBITDA margin20.7%

Returns

ROE11.9%
ROA4.3%
ROIC (approx.)7.3%
Asset turnover0.57x

Leverage & solvency

Liabilities / assets62.7%
Debt / equity1.25x
Current ratio2.84x
Interest coverage—

Cash quality & payout

Operating cash flow / net income3.32x
Accruals ratio-9.9%
Payout ratio—
Capex / revenue3.4%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20262026-03-28FY20252025-03-29
Income statement
Revenue$1.33B$1.36B
Cost of revenue$546.44M$611.87M
Gross profit$787.59M$748.96M
R&D expense$59.77M$62.72M
SG&A expense$442.42M$436.79M
Operating income$156.73M$221.82M
Interest expense$19.30M$35.90M
Pretax income$128.03M$212.07M
Income tax$30.72M$44.39M
Net income$97.31M$167.68M
EBITDA$268.45M$337.40M
EPS (basic)2.063.33
EPS (diluted)2.053.31
Weighted avg. shares (diluted)47.35M50.73M
Balance sheet
Cash & equivalents$245.44M$306.76M
Receivables$216.85M$202.66M
Inventory$306.37M$365.14M
Current assets$834.88M$934.98M
PP&E, net$305.76M$284.05M
Goodwill$656.37M$604.27M
Intangibles$447.65M$455.74M
Total assets$2.40B$2.45B
Current liabilities$282.60M$578.11M
Short-term debt$5.01M$303.56M
Long-term debt$1.22B$921.23M
Total debt$1.22B$1.22B
Total liabilities$1.60B$1.63B
Shareholders' equity$796.32M$820.84M
Net debt$979.14M$918.02M
Shares outstanding45.25M48.22M
Cash flow statement
Operating cash flow$293.22M$181.72M
Capital expenditure$32.78M$39.28M
Free cash flow$260.44M$142.45M
Investing cash flow-$179.55M-$161.90M
Financing cash flow-$178.46M$108.82M
Depreciation & amortization$111.72M$115.59M
Stock-based compensation$33.83M$29.64M
Share buybacks$175.00M$225.00M

Free plan shows the latest 2 periods; Pro shows all 18 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.